Early Neointimal Coverage and Vasodilator Response Following Biodegradable Polymer Sirolimus-Eluting vs. Durable Polymer Zotarolimus-Eluting Stents in Patients With Acute Coronary Syndrome-Reference-Cited by-同舟云学术

Early Neointimal Coverage and Vasodilator Response Following Biodegradable Polymer Sirolimus-Eluting vs. Durable Polymer Zotarolimus-Eluting Stents in Patients With Acute Coronary Syndrome

Published:2015 Issue:2 Volume:79 Page:360-367
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Karjalainen Pasi P.¹,Varho Ville²,Nammas Wail²,Mikkelsson Jussi¹,Pietilä Mikko²,Ylitalo Antti¹,Airaksinen Juhani K.E.²,Sia Jussi³,Nyman Kai⁴,Biancari Fausto⁵,Kiviniemi Tuomas²

Affiliation:

1. Heart Center, Satakunta Central Hospital

2. Heart Center, Turku University Hospital and University of Turku

3. Department of Cardiology, Central Ostrobothnia Central Hospital

4. Department of Medicine, Central Finland Central Hospital

5. Department of Surgery, Oulu University Hospital

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/79/2/79_CJ-14-1000/_pdf

Reference30 articles.

1. 1. Palmerini T, Biondi-Zoccai G, Riva DD, Stettler C, Sangiorgi D, D’Ascenzo F, et al. Stent thrombosis with drug-eluting and bare-metal stents: Evidence from a comprehensive network meta-analysis. Lancet 2012; 379: 1393–1402.

2. 2. Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, et al. Pathological correlates of late drug-eluting stent thrombosis: Strut coverage as a marker of endothelialization. Circulation 2007; 115: 2435–2441.

3. 3. Miyazaki S, Hiasa Y, Takahashi T, Yano Y, Minami T, Murakami NF, et al. In vivo optical coherence tomography of very late drug-eluting stent thrombosis compared with late in-stent restenosis. Circ J 2012; 76: 390–398.

4. 4. Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: Should we be cautious? Circulation 2004; 109: 701–705.

5. 5. Cook S, Ladich E, Nakazawa G, Eshtehardi P, Neidhart M, Vogel R, et al. Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis. Circulation 2009; 120: 391–399.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Importance of Short-Term Neointimal Coverage of Drug-Eluting Stents in the Duration of Dual Antiplatelet Therapy;Journal of Clinical Medicine;2024-03-17

2. Optimal time of dual antiplatelet therapy in patients with coronary heart disease (literature review);The Siberian Journal of Clinical and Experimental Medicine;2024-01-12

3. 48-Month Clinical Outcomes and Prognostic Factors in an All-Comers Population with Acute Coronary Syndrome and Chronic Coronary Syndrome Undergoing Percutaneous Coronary Intervention with a Sirolimus-Eluting Stent;Journal of Personalized Medicine;2023-11-03

4. The Biotronik Stent Family;Interventional Cardiology;2022-05-06

5. Early vascular healing of ultra-thin strut polymer-free sirolimus-eluting stents in acute coronary syndrome: USUI-ACS study;Cardiovascular Intervention and Therapeutics;2022-04-27